The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder

Psychopharmacology

Volumn 174, Issue 4, 2004, Pages 525-529

  Durham, L Kathryn ^a   Webb, Suzin M ^a   Milos, Patrice M ^a   Clary, Cathryn M ^b   Seymour, Albert B ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b Pfizer Global Pharmaceuticals   (United States)

Author keywords

5HTTLPR; Genotype; Major depressive disorder; Placebo; Sertraline

Indexed keywords

PLACEBO; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAMILTON SCALE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

EID: 4344641185     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1562-3     Document Type: Article

References (17)

1. Arias B, Catalan R, Gasto C, Imaz ML, Gutierrez B, Pintor L Fananas L (2001) Genetic variability in the promoter region of the serotonin transporter gene is associated with clinical remission of major depression after long term treatment with cetalopram. World federation of societies of biological psychiatry, vol 2. The World Journal of Biological Psychiatry, Berlin, p 9S
2. Collier DA, Stober G, Li T, Heils A, Catalano M, Debella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1:453-460
3. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
4. Guy W (1976) ECDEU assessment manual for psychopharmacology, revised edn. US Department of Health, Education, and Welfare, Washington
5. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296
6. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624
7. Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG, Carroll BJ (2000) Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11:215-219
8. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenbert BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
9. Nakamura M, Ueno S, Sano A, Tanabe H (2000) The human serotonin transporter gene-linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 5:32-38
10. Pollock BG, Ferrell, RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Davis S, Kirshner MA, Houck PR, Stack JA, Reynolds CF III, Kupfer DJ (2000) Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23:587-590
11. Ramamoorthy S, Bauman AL, Moore KR, Han K, Yang-Geng T, Chang AS, Ganapathy V, Blakely RD (1993) Antidepressant and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546
12. Rausch JL, Johnson ME, Fei Y, Li JQ, Shendarkar N, Hobby HM, Ganapathy V, Leibach RH (2002) Initial conditions of serotonin transporter kinetics and genotype: influence of SSRI treatment trial outcome. Biol Psychiatry 51:723-732
13. Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KRR, Shiovita T, Weihs K (2003) An eight-week, multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 160:1277-1285
14. Smeraldi E, Zanardi R, Benedetti F, Dibella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508-511
15. Whyte EM, Pollock BG, Wagner WR, Mulsant BH, Ferrell RJD, Mazumdar S, Reynolds CF III (2001) Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry 158:2074-2076
16. Yoshida K, Ito K, Sato K, Takahashi H, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K (2002) Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 26:383-386
17. Zanardi R, Benedetti F, Dibella D, Catalano M, Smeraldi E (2000) Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. Clin Psychopharmacol 20:105-107